Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MoelisFRA:17M -0.98%83 3-Year EBITDA Growth Rate is 4.20% as of Jun. 2026, which is 100% above its 10-year median of 2.10. GuruFocus rates FRA:17M with a GF Score™ of 83/100 and a GF Value™ of €70.72 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 504 Capital Markets companies, Moelis ranks worse than 65.67% on this metric.
During the past 12 months, Moelis's average EBITDA Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 4.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Moelis was 17.20% per year. The lowest was -31.80% per year. And the median was 2.10% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Moelis 3-Year EBITDA Growth Rate Related Terms
FRA:17M vs MRX, PIPR, PJT: 3-Year EBITDA Growth Rate Comparison
For the Capital Markets subindustry, Moelis's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moelis 3-Year EBITDA Growth Rate vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Moelis's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Moelis's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 4.20% mean?
Moelis (FRA:17M) has a 3-Year EBITDA Growth Rate of 4.20% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Moelis and its competitors. This is 100% above median its historical median of 2.10. According to the industry distribution chart, Moelis ranks #331 out of 504 companies in the Capital Markets industry, placing it in the top 65.7%.
Is Moelis' 3-Year EBITDA Growth Rate too high?
Moelis' current 3-Year EBITDA Growth Rate of 4.20% is 100% above median its 10-year median of 2.10. The Capital Markets industry median 3-Year EBITDA Growth Rate is 14.75. Moelis' value of 4.20% is 71.5% below this industry median. Based on the distribution chart, Moelis ranks #331 out of 504 companies in the Capital Markets industry, which is below the industry midpoint. Overall, Moelis has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Moelis' 3-Year EBITDA Growth Rate compare to MRX and PIPR?
According to the Capital Markets industry distribution chart, Moelis ranks #331 out of 504 companies for 3-Year EBITDA Growth Rate. This places Moelis in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 14.75. Moelis' value of 4.20% is 71.5% below this benchmark. While the company's 10-year median is 2.10 vs. the industry median of 14.75, Moelis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Capital Markets company?
The median 3-Year EBITDA Growth Rate among Capital Markets companies is 14.75, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moelis's current 3-Year EBITDA Growth Rate of 4.20% is 71.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Moelis and its competitors. For the Capital Markets industry, the median 3-Year EBITDA Growth Rate is 14.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moelis's current 3-Year EBITDA Growth Rate is 4.20%, which is 100% above median its own 10-year median of 2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moelis stock overvalued right now?
Based on GuruFocus' analysis, Moelis (FRA:17M) is currently considered Modestly Undervalued. The stock's GF Value™ is €70.72, compared to a current price of €50.50 — trading 28.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 4.20%, which is 100% above median its 10-year median of 2.10 and 71.5% below the Capital Markets industry median of 14.75. Moelis' overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Moelis (FRA:17M), the current 3-Year EBITDA Growth Rate is 4.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moelis (FRA:17M) Overvalued in 2026?
Based on GuruFocus' analysis, Moelis stock appears to be undervalued.
The current stock price of €50.50 is trading 28.6% below its estimated GF Value™ of €70.72.
GuruFocus considers Moelis to be Modestly Undervalued.
Key valuation signals for FRA:17M:
3-Year EBITDA Growth Rate: 4.20% (100% above median its 10-year median of 2.10)
GF Value™: €70.72 vs. price of €50.50 (28.6% below fair value)
Industry Position: 71.5% below the Capital Markets median (#331 of 504)
No single metric tells the full story. See the FRA:17M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.
83GF Score
Get the complete analysis for FRA:17M
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:17M has been successfully added to your 
